Literature DB >> 34469539

Are Homologous Recombination Deficiency Mutations Relevant in Colorectal Cancer?

Michael S Lee1, Scott Kopetz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34469539      PMCID： PMC8826393          DOI： 10.1093/jnci/djab170

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  23 in total

Review 1.  The DNA Damaging Revolution: PARP Inhibitors and Beyond.

Authors:  Timothy A Yap; Ruth Plummer; Nilofer S Azad; Thomas Helleday
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

2.  Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Authors:  Kathleen N Moore; Angeles Alvarez Secord; Melissa A Geller; David Scott Miller; Noelle Cloven; Gini F Fleming; Andrea E Wahner Hendrickson; Masoud Azodi; Paul DiSilvestro; Amit M Oza; Mihaela Cristea; Jonathan S Berek; John K Chan; Bobbie J Rimel; Daniela E Matei; Yong Li; Kaiming Sun; Katarina Luptakova; Ursula A Matulonis; Bradley J Monk
Journal:  Lancet Oncol       Date:  2019-04-01       Impact factor: 41.316

3.  A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

Authors:  Sabrina Arena; Giorgio Corti; Erika Durinikova; Monica Montone; Nicole M Reilly; Mariangela Russo; Annalisa Lorenzato; Pamela Arcella; Luca Lazzari; Giuseppe Rospo; Massimiliano Pagani; Carlotta Cancelliere; Carola Negrino; Claudio Isella; Alice Bartolini; Andrea Cassingena; Alessio Amatu; Gianluca Mauri; Andrea Sartore-Bianchi; Gloria Mittica; Enzo Medico; Silvia Marsoni; Michael Linnebacher; Sergio Abrignani; Salvatore Siena; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Clin Cancer Res       Date:  2019-12-12       Impact factor: 12.531

4.  Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.

Authors:  Nicolai J Birkbak; Zhigang C Wang; Daniel P Silver; Zoltan Szallasi; Andrea L Richardson; Ji-Young Kim; Aron C Eklund; Qiyuan Li; Ruiyang Tian; Christian Bowman-Colin; Yang Li; April Greene-Colozzi; J Dirk Iglehart; Nadine Tung; Paula D Ryan; Judy E Garber
Journal:  Cancer Discov       Date:  2012-03-22       Impact factor: 39.397

Review 5.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

6.  Olaparib for Metastatic Castration-Resistant Prostate Cancer.

Authors:  Johann de Bono; Joaquin Mateo; Karim Fizazi; Fred Saad; Neal Shore; Shahneen Sandhu; Kim N Chi; Oliver Sartor; Neeraj Agarwal; David Olmos; Antoine Thiery-Vuillemin; Przemyslaw Twardowski; Niven Mehra; Carsten Goessl; Jinyu Kang; Joseph Burgents; Wenting Wu; Alexander Kohlmann; Carrie A Adelman; Maha Hussain
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

7.  The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer.

Authors:  Hiroyuki Arai; Andrew Elliott; Joanne Xiu; Jingyuan Wang; Francesca Battaglin; Natsuko Kawanishi; Shivani Soni; Wu Zhang; Joshua Millstein; Davendra Sohal; Richard M Goldberg; Michael J Hall; Aaron J Scott; Moh'd Khushman; Jimmy J Hwang; Emil Lou; Benjamin A Weinberg; John L Marshall; Albert C Lockhart; Phillip Stafford; Jian Zhang; Roberto Moretto; Chiara Cremolini; W Michael Korn; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2021-03-25       Impact factor: 12.531

Review 8.  DNA double-strand break repair-pathway choice in somatic mammalian cells.

Authors:  Ralph Scully; Arvind Panday; Rajula Elango; Nicholas A Willis
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07-01       Impact factor: 113.915

9.  BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.

Authors:  Kara N Maxwell; Bradley Wubbenhorst; Brandon M Wenz; Daniel De Sloover; John Pluta; Lyndsey Emery; Amanda Barrett; Adam A Kraya; Ioannis N Anastopoulos; Shun Yu; Yuchao Jiang; Hao Chen; Nancy R Zhang; Nicole Hackman; Kurt D'Andrea; Robert Daber; Jennifer J D Morrissette; Nandita Mitra; Michael Feldman; Susan M Domchek; Katherine L Nathanson
Journal:  Nat Commun       Date:  2017-08-22       Impact factor: 14.919

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312
View more
  1 in total

1.  HRD-MILN: Accurately estimate tumor homologous recombination deficiency status from targeted panel sequencing data.

Authors:  Xuwen Wang; Ying Xu; Yinbin Zhang; Shenjie Wang; Xuanping Zhang; Xin Yi; Shuqun Zhang; Jiayin Wang
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.